Autoimmune/Cholestatic/Biliary Diseases

Top Story

AASLD Foundation presents grants to young hepatologists for research, careers

AASLD Foundation presents grants to young hepatologists for research, careers
July 18, 2019

Maralixibat bile acid inhibitor enters phase 3 trial for pediatric PFIC

July 11, 2019
Mirum Pharmaceuticals dosed the first patient in a phase 3 trial of maralixibat, its lead drug candidate for the treatment of pediatric patients with progressive…

Oral Korsuva enters phase 2 for treatment of PBC-related pruritus

June 28, 2019
Cara Therapeutics announced the initiation of a phase 2 trial of oral Korsuva for the treatment of pruritus in patients with hepatic impairment due to primary biliary…
In the Journals

Gene pattern predicts transplant-free survival for children with biliary atresia

June 19, 2019
Researchers identified a 14-gene expression pattern that predicted transplant-free survival for 2 years in pediatric patients with biliary atresia, according to a study…
More Headlines »
CME

Risky Business: Prophylaxis and Treatment of Cytomegalovirus in the Transplantation Setting

This activity is supported by educational grants from Merck & Co., Inc. and Shire.

Cytomegalovirus (CMV) is a common herpes virus that affects 50% to 80% of the US population. Disease from reactivation…
More »
GI Bookshelf

Question 28: I Have A Patient With Biliary-Type Pain, But No Other Evidence Of Bile Duct Disease (Normal Diameter Duct On Ultrasound, Normal Liver Function Tests). How Should Such A Patient Be Managed?

From Curbside Consultation in Endoscopy: 49 Clinical Questions, Second Edition
More »
Video
Meeting News

VIDEO: Expert discusses cases of hepatitis E, PSC in patients with IBD

November 14, 2017
More »